KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Payables: 2009-2025

Historic Payables for Idexx Laboratories (IDXX) over the last 16 years, with Sep 2025 value amounting to $122.3 million.

  • Idexx Laboratories' Payables rose 10.54% to $122.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $473.2 million, marking a year-over-year increase of 3.72%. This contributed to the annual value of $114.2 million for FY2024, which is 3.22% up from last year.
  • As of Q3 2025, Idexx Laboratories' Payables stood at $122.3 million, which was up 4.87% from $116.6 million recorded in Q2 2025.
  • In the past 5 years, Idexx Laboratories' Payables registered a high of $127.3 million during Q2 2022, and its lowest value of $86.7 million during Q3 2021.
  • Moreover, its 3-year median value for Payables was $116.6 million (2025), whereas its average is $115.2 million.
  • Per our database at Business Quant, Idexx Laboratories' Payables soared by 55.77% in 2021 and then fell by 15.40% in 2023.
  • Over the past 5 years, Idexx Laboratories' Payables (Quarterly) stood at $116.1 million in 2021, then fell by 5.10% to $110.2 million in 2022, then grew by 0.38% to $110.6 million in 2023, then rose by 3.22% to $114.2 million in 2024, then climbed by 10.54% to $122.3 million in 2025.
  • Its last three reported values are $122.3 million in Q3 2025, $116.6 million for Q2 2025, and $120.1 million during Q1 2025.